Abbott Faces Calls For Compulsory License For Norvis
Abbott Laboratories' nearly fivefold increase on its AIDS drug Norvis has prompted calls from government officials for a compulsory license for a generic version of the drug before its patent expiration,...To view the full article, register now.
Already a subscriber? Click here to view full article